Prudential Financial
ALLO icon

Prudential Financial’s Allogene Therapeutics ALLO Stock Holding History

Prudential Financial’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.3K Buy
46,285
+21,285
+85% +$46.7K ﹤0.01% 2345
2026
Q1 		$61K Buy
+25,000
New +$50.1K ﹤0.01% 2288
2025
Q4 		– Sell
-15,930
Closed -$19.8K – 2219
2025
Q3 		$19.8K Hold
15,930
– – ﹤0.01% 2401
2025
Q2 		$18K Buy
15,930
+4,045
+34% +$5.38K ﹤0.01% 2408
2025
Q1 		$17.4K Buy
+11,885
New +$22.4K ﹤0.01% 2260
2024
Q4 		– Sell
-214,495
Closed -$601K – 2289
2024
Q3 		$601K Sell
214,495
-17,401
-8% -$46.4K ﹤0.01% 2136
2024
Q2 		$540K Buy
231,896
+33,484
+17% +$98.8K ﹤0.01% 2152
2024
Q1 		$887K Sell
198,412
-180,428
-48% -$753K ﹤0.01% 1907
2023
Q4 		$1.22M Buy
+378,840
New +$1.07M ﹤0.01% 1721
2023
Q3 		– Sell
-33,890
Closed -$168K – 2595
2023
Q2 		$168K Sell
33,890
-54,541
-62% -$295K ﹤0.01% 2450
2023
Q1 		$437K Buy
+88,431
New +$567K ﹤0.01% 2133
2021
Q1 		– Sell
-102,036
Closed -$2.58M – 2489
2020
Q4 		$2.58M Sell
102,036
-162,346
-61% -$5.29M ﹤0.01% 1305
2020
Q3 		$9.97M Buy
264,382
+248,237
+1,538% +$9.36M 0.02% 655
2020
Q2 		$692K Buy
+16,145
New +$584K ﹤0.01% 1801

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Prudential Financial's ALLO Position: Q2 2026 in Review

Prudential Financial increased its Allogene Therapeutics (ALLO) stake by 85% in Q2 2026, buying an estimated $46.7K and bringing the position to 46,285 shares worth $96.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

Prudential Financial first reported a position in ALLO in Q2 2020 and has held it in 14 quarters since. The position peaked at $9.97M in Q3 2020. 210 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • Prudential Financial held 46,285 shares of Allogene Therapeutics worth $96.3K as of Q2 2026.
  • Prudential Financial bought 21,285 Allogene Therapeutics shares in Q2 2026, an estimated $46.7K.
  • Allogene Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2345 holding.
  • Prudential Financial first reported a position in Allogene Therapeutics in Q2 2020 and has held it in 14 quarters since.
  • Prudential Financial's Allogene Therapeutics position peaked at $9.97M in Q3 2020.
  • 210 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.